Substituted 1,2,4-oxodiazoles as Potent Inhibitors of Human 11bgr; - hydroxysteroid Dehydrogenase Type 1 (11bgr;-HSD1): Virtual Screening and Docking Results

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|3|226-233

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.3, 2016-03, pp. : 226-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type 1 11 &bgr;-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors

By  

Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-03 ,pp. : 642-649

Bentham Science Publishers

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents

By Webster Scott Peter   Pallin Thomas David  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 12, 2007-12 ,pp. : 1407-1422

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule 11&bgr;- Hydroxysteroid Dehydrogenase Type 1 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1464-1475

Bentham Science Publishers

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes

By Morgan Stuart A   Tomlinson Jeremy W  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1067-1076

Informa Healthcare

Access to resources Recommend Favorite